| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-18 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-17 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-16 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.29 | 3e-16 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.3 | 1e-15 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-15 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.28 | 4e-15 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-14 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-14 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.26 | 5e-14 |